{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:21:07Z","timestamp":1780543267616,"version":"3.54.1"},"reference-count":122,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.canrad.2025.104769","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:47:08Z","timestamp":1764334028000},"page":"104769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radiotherapy of bone metastases: 2025 update"],"prefix":"10.1016","volume":"29","author":[{"given":"Nicolas","family":"Martz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Christophe","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Beldjoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Chamois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Supiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilien","family":"Rog\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Thureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.canrad.2025.104769_bib0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5489\/cuaj.117","article-title":"Management of skeletal-related events in patients with advanced prostate cancer and bone metastases: incorporating new agents into clinical practice","volume":"6","author":"So","year":"2012","journal-title":"Can Urol Assoc J"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10585-019-09983-0","article-title":"Factors related to the quality of life in patients with bone metastases","volume":"36","author":"Shinoda","year":"2019","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10555-025-10262-6","article-title":"State-of-the-art of multidisciplinary approach of bone metastasis-directed therapy: review and challenging questions for preparation of a GEMO practice guidelines","volume":"44","author":"Mesny","year":"2025","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jbspin.2018.03.005","article-title":"Bone metastases from lung cancer: a paradigm for multidisciplinary oncorheumatology management","volume":"86","author":"Confavreux","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.canrad.2025.104769_bib0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.radonc.2022.01.030","article-title":"Defining the expected 30-day mortality for patients undergoing palliative radiotherapy: a meta-analysis","volume":"168","author":"Kutzko","year":"2022","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0030","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.ijrobp.2011.02.008","article-title":"Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases","volume":"82","author":"Chow","year":"2012","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104769_bib0035","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.radonc.2018.01.003","article-title":"Update of the systematic review of palliative radiation therapy fractionation for bone metastases","volume":"126","author":"Rich","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104769_bib0040","doi-asserted-by":"crossref","first-page":"103775","DOI":"10.1016\/j.critrevonc.2022.103775","article-title":"Stereotactic body radiation therapy versus conventional external beam radiation therapy for painful bone metastases: a systematic review and meta-analysis of randomized trials","volume":"178","author":"Lee","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.canrad.2025.104769_bib0045","doi-asserted-by":"crossref","first-page":"109969","DOI":"10.1016\/j.radonc.2023.109969","article-title":"Efficacy and safety of SBRT for spine metastases: a systematic review and meta-analysis for preparation of an ESTRO practice guideline","volume":"190","author":"Guninski","year":"2024","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijrobp.2022.05.043","article-title":"Mature local control and reirradiation rates comparing spine stereotactic body radiation therapy with conventional palliative external beam radiation therapy","volume":"114","author":"Zeng","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104769_bib0055","doi-asserted-by":"crossref","first-page":"109966","DOI":"10.1016\/j.radonc.2023.109966","article-title":"ESTRO clinical practice guideline: stereotactic body radiotherapy for spine metastases","volume":"190","author":"Guckenberger","year":"2024","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.prro.2024.04.018","article-title":"External beam radiation therapy for palliation of symptomatic bone metastases: an ASTRO clinical practice guideline","volume":"14","author":"Alcorn","year":"2024","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104769_bib0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ijrobp.2013.03.022","article-title":"Pain flare is a common adverse event in steroid-na\u00efve patients after spine stereotactic body radiation therapy: a prospective clinical trial","volume":"86","author":"Chiang","year":"2013","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.21037\/apm.2016.12.04","article-title":"Efficacy of single fraction conventional radiation therapy for painful uncomplicated bone metastases: a systematic review and meta-analysis","volume":"6","author":"Chow","year":"2017","journal-title":"Ann Palliat Med"},{"issue":"4","key":"10.1016\/j.canrad.2025.104769_bib0075","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.prro.2022.01.011","article-title":"Development and internal validation of a recursive partitioning analysis-based model predictive of pain flare incidence after spine stereotactic body radiation therapy","volume":"12","author":"Kowalchuk","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"15","key":"10.1016\/j.canrad.2025.104769_bib0080","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S1470-2045(15)00199-0","article-title":"Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial","volume":"16","author":"Chow","year":"2015","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104769_bib0085","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijrobp.2020.05.007","article-title":"Dexamethasone for the prevention of a pain flare after palliative radiation therapy for painful bone metastases: the multicenter double-blind placebo-controlled 3-armed randomized Dutch DEXA study","volume":"108","author":"van der Linden","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.canrad.2025.104769_bib0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s000660050062","article-title":"[Palliative radiotherapy of bone metastases. A retrospective analysis of 176 patients]","volume":"175","author":"Koswig","year":"1999","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.adro.2016.11.001","article-title":"Limited short-term effect of palliative radiation therapy on quantitative computed tomography-derived bone mineral density in femora with metastases","volume":"2","author":"Eggermont","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1186\/s12885-018-4777-8","article-title":"Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases\u00a0\u2013\u00a0a randomized controlled trial","volume":"18","author":"Sprave","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0167-8140(03)00232-9","article-title":"Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions: results from a randomised trial","volume":"69","author":"van der Linden","year":"2003","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0110","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.prro.2018.02.001","article-title":"Assessing the utility of the spinal instability neoplastic score (SINS) to predict fracture after conventional radiation therapy (RT) for spinal metastases","volume":"8","author":"Shi","year":"2018","journal-title":"Pract Radiat Oncol"},{"issue":"27","key":"10.1016\/j.canrad.2025.104769_bib0115","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","article-title":"Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score","volume":"31","author":"Sahgal","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semradonc.2022.11.006","article-title":"Stereotactic body radiation therapy for spinal metastases: benefits and limitations","volume":"33","author":"Guckenberger","year":"2023","journal-title":"Semin Radiat Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104769_bib0125","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamaoncol.2023.0356","article-title":"Stereotactic radiosurgery vs. conventional radiotherapy for localized vertebral metastases of the spine: phase 3 results of NRG Oncology\/RTOG 0631 randomized clinical trial","volume":"9","author":"Ryu","year":"2023","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","article-title":"Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy","volume":"128","author":"Sprave","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0360-3016(94)E0310-G","article-title":"Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease","volume":"31","author":"Townsend","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.radonc.2016.07.009","article-title":"Lack of clinical evidence for postoperative radiotherapy after surgical fixation of impending or actual pathologic fractures in the long bones in patients with cancer; a systematic review","volume":"121","author":"Willeumier","year":"2016","journal-title":"Radiother Oncol"},{"issue":"9486","key":"10.1016\/j.canrad.2025.104769_bib0145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","article-title":"Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial","volume":"366","author":"Patchell","year":"2005","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.canrad.2025.104769_bib0150","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.clon.2020.07.022","article-title":"Surgical and radiotherapeutic management of malignant extradural spinal cord compression","volume":"32","author":"Loblaw","year":"2020","journal-title":"Clin Oncol R Coll Radiol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104769_bib0155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/neuonc\/noad206","article-title":"The role of minimally invasive surgery within a multidisciplinary approach for patients with metastatic spine disease over a decade: a systematic review","volume":"26","author":"Schupper","year":"2024","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0160","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.prro.2021.10.004","article-title":"Stereotactic radiosurgery for postoperative spine malignancy: a systematic review and International Stereotactic Radiosurgery Society Practice Guidelines","volume":"12","author":"Faruqi","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104769_bib0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3171\/2016.8.SPINE16121","article-title":"Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey","volume":"26","author":"Redmond","year":"2017","journal-title":"J Neurosurg Spine"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0170","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ijrobp.2010.01.024","article-title":"Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression","volume":"79","author":"Rades","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/cns.14.53","article-title":"Is there any role for stereotactic body radiotherapy in the management of metastatic epidural spinal cord compression?","volume":"4","author":"Lo","year":"2015","journal-title":"CNS Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0180","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104769_bib0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.canrad.2025.104769_bib0190","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0195","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"issue":"10422","key":"10.1016\/j.canrad.2025.104769_bib0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(23)01857-3","volume":"403","author":"Tsai","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.canrad.2025.104769_bib0205","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamaoncol.2023.0161","article-title":"Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer: the EXTEND phase 2 randomized clinical trial","volume":"9","author":"Tang","year":"2023","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0210","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs. stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104769_bib0215","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.eururo.2018.06.004","article-title":"Stereotactic abative body radiotherapy (SABR) for oligometastatic prostate cancer: a prospective clinical trial","volume":"74","author":"Siva","year":"2018","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.32509","article-title":"Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: interim outcomes of a prospective clinical trial","volume":"146","author":"Bowden","year":"2020","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.canrad.2025.104769_bib0225","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S1470-2045(21)00528-3","article-title":"Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial","volume":"22","author":"Tang","year":"2021","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104769_bib0230","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.euo.2022.06.008","article-title":"Stereotactic ablative radiation for systemic therapy-na\u00efve oligometastatic kidney cancer","volume":"5","author":"Hannan","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0235","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.ijrobp.2023.12.045","article-title":"Meta-Analysis of Stereotactic Body Radiation ThERapy in Nonspine BONE Metastases (MASTER-BONES)","volume":"119","author":"Moraes","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2025.104769_bib0240","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ijrobp.2023.12.051","article-title":"Clinical outcomes after stereotactic body radiation therapy for nonspinal bone metastases: a systematic review and meta-analysis","volume":"119","author":"Singh","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0245","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/jpm.2009.9633","article-title":"Therapeutic guidelines for the treatment of bone metastasis: a report from the American College of Radiology Appropriateness Criteria Expert Panel on radiation oncology","volume":"12","author":"Janjan","year":"2009","journal-title":"J Palliat Med"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0250","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.23.00753","article-title":"Prophylactic radiation therapy versus standard of care for patients with high-risk asymptomatic bone metastases: a multicenter, randomized phase II clinical trial","volume":"42","author":"Gillespie","year":"2024","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.canrad.2025.104769_bib0255","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2967\/jnumed.116.189183","article-title":"A prospective study comparing (99mTc)-hydroxyethylene-diphosphonate planar bone scintigraphy and whole-body SPECT\/CT with (18F)-fluoride PET\/CT and (18F)-fluoride PET\/MRI for diagnosing bone metastases","volume":"58","author":"L\u00f6fgren","year":"2017","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0260","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1148\/rg.345130061","article-title":"Newer PET application with an old tracer: role of (18F)-NaF skeletal PET\/CT in oncologic practice","volume":"34","author":"Bastawrous","year":"2014","journal-title":"Radiographics"},{"key":"10.1016\/j.canrad.2025.104769_bib0265","series-title":"Qualit\u00e9 et s\u00e9curit\u00e9 des radiochirurgies et des radioth\u00e9rapies st\u00e9r\u00e9otaxiques. Rapport SFPM no\u00a035","author":"Dedieu","year":"2019"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0270","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ijrobp.2011.12.039","article-title":"Impact of immobilization on intrafraction motion for spine stereotactic body radiotherapy using cone beam computed tomography","volume":"84","author":"Li","year":"2012","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104769_bib0275","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/j.ijrobp.2011.06.1980","article-title":"Spine stereotactic body radiotherapy utilizing cone-beam ct image-guidance with a robotic couch: intrafraction motion analysis accounting for all six degrees of freedom","volume":"82","author":"Hyde","year":"2012","journal-title":"Int J Radiat Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104769_bib0280","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/0284186X.2015.1119885","article-title":"Stereotactic body radiotherapy for spine and bony pelvis using flattening filter free volumetric modulated arc therapy, 6D cone-beam CT and simple positioning techniques: treatment time and patient stability","volume":"55","author":"Dahele","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2025.104769_bib0285","doi-asserted-by":"crossref","first-page":"103825","DOI":"10.1016\/j.critrevonc.2022.103825","article-title":"Afsos-SFRO-SFH-SFNEP-SFCE-GFRP guidelines on radioinduced nausea and vomiting","volume":"180","author":"Faivre","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.canrad.2025.104769_bib0290","doi-asserted-by":"crossref","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27","author":"Roila","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2025.104769_bib0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0959-8049(05)80011-5","article-title":"Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial","volume":"30","author":"S\u00f8rensen","year":"1994","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.canrad.2025.104769_bib0300","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ijrobp.2016.07.027","article-title":"High-dose hypofractionated radiation therapy for noncompressive vertebral metastases in combination with zoledronate: a phase 1 study","volume":"96","author":"Pichon","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2025.104769_bib0305","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ijrobp.2024.10.017","article-title":"Irradiated bone marrow volume is associated with hematologic toxicity in patients with multiple myeloma","volume":"121","author":"Zhang","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104769_bib0310","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2022.06.002","article-title":"ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases","volume":"173","author":"Oldenburger","year":"2022","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.canrad.2025.104769_bib0315","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/biomedicines8120548","article-title":"Targeting stereotactic body radiotherapy on metabolic PET- and immuno-PET-positive vertebral metastases","volume":"8","author":"Pichon","year":"2020","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.canrad.2025.104769_bib0320","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ijrobp.2018.03.010","article-title":"Impact of magnetic resonance imaging on gross tumor volume delineation in non-spine bony metastasis treated with stereotactic body radiation therapy","volume":"102","author":"Raman","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104769_bib0325","doi-asserted-by":"crossref","first-page":"110717","DOI":"10.1016\/j.radonc.2025.110717","article-title":"Stereotactic body radiotherapy for non-spine bone metastases: a meta-analysis and international stereotactic radiosurgery society (ISRS) clinical practice guidelines","volume":"205","author":"Nguyen","year":"2025","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0330","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery","volume":"83","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104769_bib0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2019.11.026","article-title":"International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT)","volume":"145","author":"Dunne","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104769_bib0340","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.radonc.2022.05.035","article-title":"Deviation from consensus contouring guidelines predicts inferior local control after spine stereotactic body radiotherapy","volume":"173","author":"Chen","year":"2022","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104769_bib0345","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2024.01.213","article-title":"Stereotactic body radiation therapy for sacral metastases: deviation from recommended target volume delineation increases the risk of local failure","volume":"119","author":"Moore-Palhares","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0350","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ijrobp.2015.03.037","article-title":"Outcomes for spine stereotactic body radiation therapy and an analysis of predictors of local recurrence","volume":"92","author":"Bishop","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0355","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2021.09.004","article-title":"International multi-institutional patterns of contouring practice and clinical target volume recommendations for stereotactic body radiation therapy for non-spine bone metastases","volume":"112","author":"Nguyen","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.canrad.2025.104769_bib0360","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.spinee.2025.01.019","article-title":"Single versus multiple fraction stereotactic spine radiosurgery for spinal metastases: a prospective randomized phase II trial","volume":"25","author":"Lai","year":"2025","journal-title":"Spine J"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0365","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.prro.2016.08.001","article-title":"Palliative radiation therapy for bone metastases: update of an ASTRO Evidence-Based Guideline","volume":"7","author":"Lutz","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104769_bib0370","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/j.canrad.2016.07.027","article-title":"[Radiotherapy of bone metastases]","volume":"20","author":"Thureau","year":"2016","journal-title":"Cancer Radiother"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0375","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.ijrobp.2008.12.084","article-title":"International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?","volume":"75","author":"Fairchild","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104769_bib0380","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2019.06.037","article-title":"Single vs. multiple fraction palliative radiation therapy for bone metastases: cumulative meta-analysis","volume":"141","author":"Chow","year":"2019","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.canrad.2025.104769_bib0385","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","article-title":"Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial","volume":"22","author":"Sahgal","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104769_bib0390","first-page":"33","article-title":"Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A G\u00e9tug (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey","volume":"37","author":"Vilotte","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104769_bib0395","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2022.05.024","article-title":"ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases","volume":"173","author":"van der Velden","year":"2022","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.canrad.2025.104769_bib0400","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/0284186X.2018.1468089","article-title":"The use of a simultaneous integrated boost in spinal stereotactic body radiotherapy to reduce the risk of vertebral compression fractures: a treatment planning study","volume":"57","author":"van der Velden","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2025.104769_bib0405","first-page":"100716","article-title":"Practice and principles of stereotactic body radiation therapy for spine and non-spine bone metastases","volume":"45","author":"Burgess","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0410","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00066-023-02082-w","article-title":"Radiotherapy concepts for spinal metastases-results from an online survey among radiation oncologists of the German Society for Radiation Oncology","volume":"200","author":"Waltenberger","year":"2024","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0415","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1186\/s12885-016-2947-0","article-title":"Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design","volume":"16","author":"van der Velden","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2025.104769_bib0420","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2019.01.019","article-title":"Single versus multifraction radiotherapy for spinal cord compression: a systematic review and meta-analysis","volume":"134","author":"Donovan","year":"2019","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104769_bib0425","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ijrobp.2023.01.050","article-title":"Pain response rates after conventional radiation therapy for bone metastases assessed using international consensus pain response endpoints: a systematic review and meta-analysis of initial radiation therapy and reirradiation","volume":"116","author":"Imano","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.canrad.2025.104769_bib0430","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3892\/mco.2017.1245","article-title":"Clinical outcome of patients treated with reirradiation for spine or pelvic bone metastasis: a multi-institutional analysis of 98 patients","volume":"6","author":"Suzuki","year":"2017","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0435","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijrobp.2011.10.080","article-title":"Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis","volume":"84","author":"Huisman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0440","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3171\/2012.4.SPINE11902","article-title":"Single-session and multisession CyberKnife radiosurgery for spine metastases \u2013 University of Pittsburgh and Georgetown University experience","volume":"17","author":"Heron","year":"2012","journal-title":"J Neurosurg Spine"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0445","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijrobp.2010.08.012","article-title":"Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases","volume":"81","author":"Mahadevan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0450","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3171\/2016.4.SPINE151523","article-title":"Reirradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis","volume":"25","author":"Hashmi","year":"2016","journal-title":"J Neurosurg Spine"},{"issue":"4","key":"10.1016\/j.canrad.2025.104769_bib0455","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3171\/2017.2.SPINE16976","article-title":"Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review","volume":"27","author":"Myrehaug","year":"2017","journal-title":"J Neurosurg Spine"},{"issue":"6\u20137","key":"10.1016\/j.canrad.2025.104769_bib0460","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.canrad.2024.07.009","article-title":"Reirradiation of bone metastasis: a narrative review of the literature","volume":"28","author":"Agnoux","year":"2024","journal-title":"Cancer Radiother"},{"issue":"12","key":"10.1016\/j.canrad.2025.104769_bib0465","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1080\/0284186X.2018.1503712","article-title":"Reirradiation for painful bone metastases using stereotactic body radiotherapy","volume":"57","author":"Ogawa","year":"2018","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0470","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A story of hypofractionation and the table on the wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.canrad.2025.104769_bib0475","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0480","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2019.09.038","article-title":"Spinal cord dose tolerance to stereotactic body radiation therapy","volume":"110","author":"Sahgal","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0485","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijrobp.2012.05.007","article-title":"Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice","volume":"85","author":"Sahgal","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2025.104769_bib0490","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2016.11.FOCUS16348","article-title":"Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors","volume":"42","author":"Stubblefield","year":"2017","journal-title":"Neurosurg Focus"},{"issue":"9","key":"10.1016\/j.canrad.2025.104769_bib0495","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/0284186X.2019.1620331","article-title":"Deformable image registration for radiation therapy: principle, methods, applications and evaluation","volume":"58","author":"Rigaud","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2025.104769_bib0500","series-title":"Radiobiology for the radiologist","author":"Hall","year":"2012"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0505","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/09553008414551181","article-title":"Review: total doses in fractionated radiotherapy\u00a0\u2013\u00a0implications of new radiobiological data","volume":"46","author":"Fowler","year":"1984","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"issue":"9","key":"10.1016\/j.canrad.2025.104769_bib0510","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1118\/1.2969065","article-title":"Some implications of linear-quadratic-linear radiation dose\u2013response with regard to hypofractionation","volume":"35","author":"Astrahan","year":"2008","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0515","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/09553008414551181","article-title":"Review: total doses in fractionated radiotherapy \u2013 implications of new radiobiological data","volume":"46","author":"Fowler","year":"1984","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0520","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijrobp.2009.05.023","article-title":"Spinal cord tolerance for stereotactic body radiotherapy","volume":"77","author":"Sahgal","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104769_bib0525","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1748-717X-8-7","article-title":"Stereotactic body radiation therapy in the reirradiation situation \u2013 a review","volume":"8","author":"Mantel","year":"2013","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104769_bib0530","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ijrobp.2005.03.034","article-title":"Spinal reirradiation after short-course RT for metastatic spinal cord compression","volume":"63","author":"Rades","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2025.104769_bib0535","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2007.10.059","article-title":"Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy","volume":"70","author":"Park","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104769_bib0540","series-title":"Basic clinical radiobiology","author":"Joiner","year":"2009"},{"issue":"3","key":"10.1016\/j.canrad.2025.104769_bib0545","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.radonc.2008.07.032","article-title":"Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy","volume":"91","author":"Gay","year":"2009","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104769_bib0550","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0360-3016(92)90964-J","article-title":"Spinal cord radiation tolerance","volume":"30","author":"Schultheiss","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl.","key":"10.1016\/j.canrad.2025.104769_bib0555","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.ijrobp.2009.04.095","article-title":"Radiation dose-volume effects in the spinal cord","volume":"76","author":"Kirkpatrick","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.canrad.2025.104769_bib0560","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/jjco\/hyaa178","article-title":"Efficacy and toxicity of re-irradiation spine stereotactic body radiotherapy with respect to irradiation dose history","volume":"51","author":"Ito","year":"2021","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104769_bib0565","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijrobp.2010.08.021","article-title":"Reirradiation human spinal cord tolerance for stereotactic body radiotherapy","volume":"82","author":"Sahgal","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.canrad.2025.104769_bib0570","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.21873\/anticanres.12813","article-title":"Quality of life and radiation-induced late toxicity following intensity-modulated versus three-dimensional conformal radiotherapy for patients with spinal bone metastases: results of a randomized trial","volume":"38","author":"Sprave","year":"2018","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1016\/j.canrad.2025.104769_bib0575","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/02841860600902213","article-title":"Accreditation and quality assurance for Radiation Therapy Oncology Group: multicenter clinical trials using stereotactic body radiation therapy in lung cancer","volume":"45","author":"Timmerman","year":"2006","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104769_bib0580","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.ijrobp.2008.02.074","article-title":"Dosimetric effect of translational and rotational errors for patients undergoing image-guided stereotactic body radiotherapy for spinal metastases","volume":"71","author":"Wang","year":"2008","journal-title":"Int J Radiat Oncol"},{"issue":"14","key":"10.1016\/j.canrad.2025.104769_bib0585","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1200\/JCO.2004.08.181","article-title":"Bone imaging in metastatic breast cancer","volume":"22","author":"Hamaoka","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104769_bib0590","doi-asserted-by":"crossref","first-page":"80","DOI":"10.7150\/jca.1.80","article-title":"Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST","volume":"1","author":"Costelloe","year":"2010","journal-title":"J Cancer"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0595","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3171\/2013.2.SPINE12739","article-title":"Radiation-induced vertebral compression fracture following spine stereotactic radiosurgery: clinicopathological correlation","volume":"18","author":"Al-Omair","year":"2013","journal-title":"J Neurosurg Spine"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0600","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3171\/2014.10.SPINE14444","article-title":"Tumor pseudoprogression of spinal metastasis after radiosurgery: a novel concept and case reports","volume":"22","author":"Taylor","year":"2015","journal-title":"J Neurosurg Spine"},{"issue":"16","key":"10.1016\/j.canrad.2025.104769_bib0605","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","article-title":"Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group","volume":"16","author":"Thibault","year":"2015","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104769_bib0610","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ijrobp.2024.02.010","article-title":"Magnetic resonance imaging frequency after stereotactic body radiation therapy for spine metastases","volume":"119","author":"Chen","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:01:30Z","timestamp":1765526490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825001854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":122,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1278321825001854"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104769","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy of bone metastases: 2025 update","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}],"article-number":"104769"}}